Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature

Abstract Background Nivolumab is an immune checkpoint inhibitor targeting programmed death-1 protein and has been approved for the treatment of multiple advanced malignancies. Adverse effects of immune checkpoint inhibitors are distinct from conventional cytotoxic chemotherapy and can be life-threat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Shagufta Shaheen, Hamid Mirshahidi, Gayathri Nagaraj, Chung-Tsen Hsueh
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMC 2018-05-01
Seri Bilgileri:Experimental Hematology & Oncology
Konular:
Non-small cell lung cancer
Immune checkpoint inhibitor
Nivolumab
Pericardial effusion
Corticosteroids
Online Erişim:http://link.springer.com/article/10.1186/s40164-018-0104-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller